How much funding has NUVOX PHARMA, L.L.C. raised?

NUVOX PHARMA, L.L.C. has raised $22.2M in total funding, most recently a Convertible Note round.

When was NUVOX PHARMA, L.L.C. founded?

NUVOX PHARMA, L.L.C. was founded in 2016.

Where is NUVOX PHARMA, L.L.C. headquartered?

NUVOX PHARMA, L.L.C. is headquartered in TUCSON, Arizona, United States.

What industry is NUVOX PHARMA, L.L.C. in?

NUVOX PHARMA, L.L.C. operates in Biotech, Healthcare.

How many employees does NUVOX PHARMA, L.L.C. have?

NUVOX PHARMA, L.L.C. has 1-10 employees.

NUVOX PHARMA, L.L.C.

Innovative Oxygen Therapeutics | NuvOx Pharma | Arizona

TUCSON, United States · Founded 2016 · $22.2M raised

Biotech

Healthcare

Headquarters: TUCSON, Arizona
Employees: 1–10
Founded: 2016
Business Model: B2G

Website: nuvoxpharma.com
Total Funding: $22.2M
Last Round: $7.0M Convertible NoteJan 2015

About

NuvOx Pharma is a clinical-stage pharmaceutical company based in Tucson, Arizona, developing NanO₂, a first-in-class oxygen therapeutic designed to reverse tissue hypoxia by improving oxygen flow from lungs to blood and from blood to tissue. With over 30 animal studies demonstrating therapeutic effect across seven disease indications, the company has advanced NanO₂ into multiple clinical trials including a Phase IIb randomized controlled trial in glioblastoma as a radiosensitizer, a Phase IIb trial in large-vessel occlusion stroke supported by the UK NIHR, and a Phase Ib trial in respiratory distress supported by BARDA.

Summary

NUVOX PHARMA, L.L.C. is a Biotech company based in TUCSON, United States, founded in 2016. It has raised $22.2M in total, most recently a $7.0M Convertible Note round in Jan 2015.